Xmalon 25 mg Tablet IP
Regulated Product — Business License RequiredB2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.
Product Overview
Xmalon 25 mg Tablet IP contains exemestane, a steroidal aromatase inhibitor. Its labelling describes it for the treatment of breast cancer in menopausal women, sometimes in combination with other cancer treatments to prevent the risk of recurrence. It is described as adjusting the estrogen level in the body and slowing the growth of breast cancer cells. It is taken with food at the same time every day for maximum benefit.
Product Information
The following description reflects information associated with this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.
Described Uses
- Described for the treatment of breast cancer in menopausal women
- Described as given in combination with other cancer treatments to prevent the risk of recurrence
- Described as lowering the estrogen level in the body, which stops the growth of breast cancer cells
Described Dosage & Administration
- Swallowed whole with food, at the same time every day for maximum benefit; the tablet should not be crushed, chewed, or broken
- Any specific instructions from the doctor should be followed diligently
- Blood tests to check vitamin D level or bone density may be carried out
Described Side Effects
Commonly described side effects include:
- Headache and dizziness
- Rash and itching
- Nausea and vomiting
- Increased sweating
- Increased or decreased appetite
- Weakness
- Abdominal pain and diarrhoea
- Insomnia (difficulty sleeping)
- Low blood platelets
- Hot flushes
- Constipation
- Hair loss
These are described as commonly temporary. The doctor should be consulted if they persist or are bothersome.
Precautions
- The doctor should be informed if the patient is not going through menopause and still has regular menstrual periods
- A complete medical history should be shared, with the doctor informed specifically of any kidney or liver issue and any current medications
- The doctor should be informed about pregnancy or breastfeeding
- Blood tests to check vitamin D level or bone density may be carried out
This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.
B2B, Import & Export Enquiries
SDO Pharma supports business enquiries for pharmaceutical and healthcare products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.
We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.
Request Product Information
Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.
Frequently Asked Questions
Per its labelling it contains exemestane and is used for the treatment of breast cancer in menopausal women, sometimes with other treatments to reduce recurrence risk. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.
Its labelling describes it as swallowed whole with food at the same time every day, without crushing, chewing, or breaking, following the doctor’s instructions.
Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.
Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.
Related Product Categories
SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.